Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-25-021908
Filing Date
2025-11-12
Accepted
2025-11-12 16:07:08
Documents
66
Period of Report
2025-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q form10-q.htm   iXBRL 10-Q 1190370
2 EX-31.1 ex31-1.htm EX-31.1 14530
3 EX-31.2 ex31-2.htm EX-31.2 13233
4 EX-32.1 ex32-1.htm EX-32.1 5493
5 EX-32.2 ex32-2.htm EX-32.2 5622
6 GRAPHIC form10-q_001.jpg GRAPHIC 8579
  Complete submission text file 0001493152-25-021908.txt   7180148

Data Files

Seq Description Document Type Size
7 XBRL SCHEMA FILE dyai-20250930.xsd EX-101.SCH 44592
8 XBRL CALCULATION FILE dyai-20250930_cal.xml EX-101.CAL 53589
9 XBRL DEFINITION FILE dyai-20250930_def.xml EX-101.DEF 267942
10 XBRL LABEL FILE dyai-20250930_lab.xml EX-101.LAB 451515
11 XBRL PRESENTATION FILE dyai-20250930_pre.xml EX-101.PRE 380103
68 EXTRACTED XBRL INSTANCE DOCUMENT form10-q_htm.xml XML 1190012
Mailing Address 1044 NORTH U.S. HIGHWAY ONE SUITE 201 JUPITER FL 33477
Business Address 1044 NORTH U.S. HIGHWAY ONE SUITE 201 JUPITER FL 33477 561-743-8333
DYADIC INTERNATIONAL INC (Filer) CIK: 0001213809 (see all company filings)

EIN.: 450486747 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-32513 | Film No.: 251472671
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)